Close X
Wednesday, December 4, 2024
ADVT 
International

Indian Embassy issues advisory to Indian medical students in China

Darpan News Desk IANS, 07 Nov, 2022 04:22 PM
  • Indian Embassy issues advisory to Indian medical students in China

New Delhi, Nov 7 (IANS) Indian students, who had joined the clinical medicine programme in China after November 2021 but had failed to secure license to practice as a medical doctor there, won't be eligible to appear in the Foreign Medical Graduate Examination, conducted by National Medical Commission, the Indian Embassy in Beijing said on Monday.

"The embassy has apprised the Chinese authorities concerned and medical colleges with a request that they should ensure that all Indian students coming to China for clinical medicine programme are educated, trained and facilitated, so that they can fulfill the requirements of the NMC," an embassy statement said.

The clarification from the embassy came after queries raised by students and parents regarding eligibility of those Indian students who are pursuing clinical medicine programme in China, for appearing in the qualifying examination in India.

"In this regard, the students and their parents are requested to see the Gazette Notification dated November 18, 2021, by the NMC. It has unambiguously stated in Clause 4(b) that foreign medical students must be 'registered with the respective professional regulatory body or otherwise, competent to grant license to practice medicine in their respective jurisdiction of the country in which the medical degree is awarded and at par with the license to practice medicine given to citizen of that country'," the embassy said.

Queries had also been received by the Indian Embassy on whether Indian students could work in Chinese hospitals as "assistant doctor" after completing their medical education in China but fail to obtain medical practitioner license in China. This would help them to earn a living and pay back education loans.

On this, the embassy said that it "has formally approached relevant Chinese authorities to confirm existence of such an option. The embassy will share any information, when received from the Chinese side, in its social media handles".

Prospective students and parents are advised to directly re-confirm all terms of reference of admission directly from the relevant universities in China, before accepting such admission, the statement added.

Photo courtesy of Wikipedia. 

MORE International ARTICLES

Retiree checks to rise 1.3% in 2021 amid coronavirus fallout

Retiree checks to rise 1.3% in 2021 amid coronavirus fallout
The COLA affects the personal finances of about 1 in 5 Americans, including Social Security recipients, disabled veterans and federal retirees, some 70 million people in all.

Retiree checks to rise 1.3% in 2021 amid coronavirus fallout

AP-NORC poll: New angst for caregivers in time of COVID-19

AP-NORC poll: New angst for caregivers in time of COVID-19
The Associated Press-NORC Center for Public Affairs Research poll finds that 17% of Americans say they are providing ongoing caregiving, part of an informal volunteer corps.

AP-NORC poll: New angst for caregivers in time of COVID-19

Am I immune to the coronavirus if I’ve already had it?

Am I immune to the coronavirus if I’ve already had it?
Reinfection so far has been rare. The best known example: Researchers in Hong Kong said a man had mild COVID-19 and then months later was infected again but showed no symptoms.

Am I immune to the coronavirus if I’ve already had it?

Antibody drugs are no cure but seem promising for COVID-19

Antibody drugs are no cure but seem promising for COVID-19
Antibodies are proteins the body makes when an infection occurs; they attach to a virus and help it be eliminated. Vaccines mimic an infection to spur antibody production.

Antibody drugs are no cure but seem promising for COVID-19

Lilly seeks emergency use of its antibody drug for COVID-19

Lilly seeks emergency use of its antibody drug for COVID-19
Eli Lilly and Company announced the partial results Wednesday in a news release; they have not yet been published or reviewed by independent scientists.

Lilly seeks emergency use of its antibody drug for COVID-19

Experts call Trump's rosy virus message misguided

Experts call Trump's rosy virus message misguided
The seven-day rolling average for new U.S. cases has climbed over the past two weeks to almost 42,000 per day. The nation also sees more than 700 COVID-19 deaths each day.

Experts call Trump's rosy virus message misguided